ESCRS 2024: A visionary gathering in Barcelona

The European Society of Cataract and Refractive Surgeons (ESCRS) is gearing up for its 42nd Congress, scheduled to take place from September 6-10, 2024, at the Fira de Barcelona in Spain. This prestigious event promises to be a hub of innovation and knowledge-sharing in ophthalmology.

Programme Highlights

The 2024 meeting will feature several exciting events:

• Focused Friday includes ESCRS iNovation® Day, Cornea Day, Glaucoma Day, and the Global Refractive Summit.
• Global@ Active Monday will offer sessions on telemedicine, digital ophthalmology, and international collaborations.
• A celebration of the 75th Anniversary of IOL Implantation will be a key highlight, featuring various activities and exhibitions.
• The ESCRS Arena/Tablao will host workshops, debates, and surgical simulator presentations.
• Continuing from previous meetings, ESCRS Initiatives such as the Escape Room and World Café Roundtables will engage attendees in interactive learning.

Attendees can look forward to main symposia, instructional courses, wetlabs, video sessions, posters, and oral presentations, providing a comprehensive learning experience. The congress offers ophthalmologists the opportunity to explore the latest advances and innovations in ophthalmology, network with global experts, and discover the newest industry offerings.

Preview – hot topics

From the pre-congress webinar “ESCRS eConnect webinar: ESCRS Barcelona 2024: ‘Why you shouldn’t miss it!’ – A Sneak Preview,” we know that some of the hot topics to be discussed include:

• The latest news on keratoconus
• Updates on intraocular lenses (IOLs)
• Discussions on the future of corneal refractive surgery
• Telemedicine in ophthalmology and remote eye care
• IOL exchange surgery

These topics are sure to ignite lively discussions and showcase the latest research and advancements in the field.

For more information and information on how to register visit the ESCRS congress website.

Disclosure: This article was created by the touchOPHTHALMOLOGY team utilizing AI as an editorial tool (ChatGPT (GPT-4o) [Large language model]. https://chat.openai.com/chat.) The content was developed and edited by human editors. No funding was received in the publication of this article.